Abstract
Acute respiratory viral infections (ARVI) are diseases that have important medico-social importance since they are associated with a wide distribution among the population, the risk of complications, reduced quality of life of patients, and high total cost of treatment. Aim. To assess the quality of pharmacotherapy: the frequency of prescribing drugs for children with ARVI in the healthcare institution of the Poltava region and the correspondence of drug prescriptions to clinical protocols for providing medical care and the State Formulary of Medicines of Ukraine (SFMU). Materials and methods. The quality assessment of pharmacotherapy of children with ARVI was performed using auxiliary clinical and economic methods – the frequency and formal VEN-analyses. Results. The main directions of pharmacotherapy of children with ARVI in one of the healthcare institution of the Poltava region correspond to the unified clinical protocol of the primary care for adults and children with ARVI and clinical protocols for pharmacotherapy of concomitant diseases. Using the formal VEN-analysis it has been determined that the majority of INN drugs prescribed are recommended by clinical protocols for pharmacotherapy of the main (ARVI) and associated diseases registered in patients, and are available in the SFMU (87.50 and 54.69 %, respectively). Conclusions. The formal VEN analysis has shown that the ARVI pharmacotherapy correction is needed in the healthcare institution of the Poltava region studied since a significant part of the INN drugs prescribed is absent in the SFMU (45.31 %) and in clinical protocols for the primary pharmacotherapy (ARVI) and associated diseases (17.19 %). In both medical and technological documents there are no 12.50 % of INNs prescribed. For them 11.74 % of funds (4808.81 UAH) were spent by parents of sick children; they were prescribed 8.74 % times (38 prescriptions) of the total number of prescriptions – 431.
Highlights
National University of Pharmacy Institute for Continuing Education of Pharmacy Professionals at the National University of Pharmacy*
Using the formal VEN-analysis it has been determined that the majority of INN drugs prescribed are recommended by clinical protocols for pharmacotherapy of the main (ARVI) and associated diseases registered in patients, and are available in the State Formulary of Medicines of Ukraine (SFMU) (87.50 and 54.69 %, respectively)
For children with Acute respiratory viral infections (ARVI), 92 trade names (TN) of drugs were prescribed on the basis of 63 INN of drugs and 1 dietary food supplement belonging to 19 pharmacotherapeutic groups
Summary
National University of Pharmacy Institute for Continuing Education of Pharmacy Professionals at the National University of Pharmacy*. The frequency and VEN-analysis of pharmacotherapy in children with ARVI in the healthcare institution of the Poltava region. Acute respiratory viral infections (ARVI) are diseases that have important medico-social importance since they are associated with a wide distribution among the population, the risk of complications, reduced quality of life of patients, and high total cost of treatment
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
